Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216381 · ClinicalTrials.gov registry record
Trauma Specific Frailty Index
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 500
- Enrollment target
NCT04216381: Completed study, sponsored by Methodist Health System.
NCT04216381 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216381 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Increasing age is a known predictor of morbidity and mortality after a traumatic injury with worst outcomes seen in patients with age greater than 65 years. Geriatric trauma patients are a unique cohort of patients who are highly prone to develop decompensated state following the stress of traumatic event leading to adverse outcomes. In a prospective study the primary site demonstrated the presence of frailty syndrome as a better predictor of in-hospital complications and adverse discharge disposition among geriatric trauma patients than age. Presently, Methodist Dallas Medical Center aims to participate in the large scale prospective multi-institutional validation of TSFI to assess the sensitivity and specificity of Trauma Specific Frailty Index in predicting adverse outcomes through a diverse account utilizing multiple facilities.
Primary Outcome
death of the participant
Interventions
- DIAGNOSTIC_TEST Trauma Specific Frailty Index Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2023-08-16 |
What the finished NCT04216381 record still lists
NCT04216381 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Trauma Specific Frailty Index Questionnaire is the first listed.
NCT04216381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04216381 about?
NCT04216381 is a clinical study titled "Trauma Specific Frailty Index". Increasing age is a known predictor of morbidity and mortality after a traumatic injury with worst outcomes seen in patients with age greater than 65 years. Geriatric trauma patients are a unique cohort of patients who are highly prone to develop decompensated state following the stress of traumatic...
What is the current status of trial NCT04216381?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2019-09-20. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT04216381?
The interventions under investigation include: Trauma Specific Frailty Index Questionnaire (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04216381?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI